IRCT2016021626599N1已完成1 期
Percutanous sclerotherapy of symptomatic liver hemangioma with Bleomycin, a pilot study
Vice Chancellor for Research, Tehran University of Medical Sciences0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 years 至 80 years（—）
- 性别
- All
入选标准
- •Patients with symptomatic liver hemangioma with therapeutic indication with confirmed diagnosis based on triphasic CT-scan or dynamic MRI.
- •Exclusion criteria: Those patients that their abdominal complaints could be attributed to another cause, apart from liver hemangioma
排除标准
- 未提供
研究者
相似试验
已完成
1 期
Percutaneous Sclerotherapy of Symptomatic Liver Hemangioma With BleomycinHemangioma LiverNCT03649113Tehran University of Medical Sciences25
已完成
不适用
Short-term therapy of hepatic arterial infusion chemotherapy using DSM for patients with advanced hepatocellular carcinoma: pilot studyadvanced hepatocellular carcinomaJPRN-UMIN000019344Yamaguchi University Hospital30
已完成
不适用
The effect of prophylactic use of pethidine for anxiety and post procedural pain relief in patients undergoing percutaneous liver biopsyACTRN12614001194651Gastroenterology unit, Dunedin Hospital100
尚未招募
2 期
Treatment of liver abscess by emergency doctors versus radiologistsCTRI/2024/04/065941ALL INDIA INSTITUTE OF MEDICAL SCIENCES NEW DELHI
招募中
不适用
Transjugular liver biopsy for liver damage after hematopoietic stem cell trasnplantatioliver damage after hematopoietic stem cell transplantationJPRN-UMIN000017752nivesity of Tokyo Hospital, Department of Hematology and Oncology30